Publications by authors named "B Zalunardo"
Article Synopsis
- Patients with acute pulmonary embolism (PE) and active cancer face significantly higher risks of death and major bleeding compared to those with previous cancer or no cancer.
- The study analyzed 5,056 patients categorized by cancer status, revealing that active cancer patients had a high incidence of deaths and prevalent metastatic disease.
- The type of cancer influences outcomes; lung or metastatic cancers predict death, while brain, hematological, or gastrointestinal cancers increase bleeding risks.
Article Synopsis
- Exertional dyspnea, or shortness of breath during activity, is a common issue in healthcare but its link to pulmonary embolism (PE) hasn't been thoroughly studied.
- This study aimed to determine how prevalent PE is among patients who visit the emergency room due to new-onset exertional dyspnea.
- Out of 417 patients assessed, 32.1% had confirmed PE, indicating that it's frequently present in this population, even in those without other classic signs of the condition.
Patients with peripheral arterial disease (PAD) are at high risk of major adverse cardiac events (MACE) and major adverse limb events (MALE). Recently, antithrombotic therapies employing antiplatelet and anticoagulant drugs have proven to be valid in reducing MACE in patients with PAD and polyvascular disease and MALE, particularly in patients who have already been revascularized and remain at increased risk of MALE. However, more aggressive antithrombotic therapies lead to an increased risk of bleeding.
View Article and Find Full Text PDFCancer is a leading cause of death. Venous thromboembolism (VTE) is an often-overlooked cause of morbidity and mortality in cancer patients that can be readily prevented and treated. Actions are needed to reduce the morbidity and mortality of patients with cancer-associated thrombosis (CAT).
View Article and Find Full Text PDF